REXAHN PHARMACEUTICALS, INC. Bonus & Incentive Agreements
6 Contracts & Agreements
- Form of Stock Option Grant Notice issued under the Ocuphire Pharma, Inc. 2020 Equity Incentive Plan (Filed With SEC on March 30, 2023)
- Form of Restricted Stock Unit Grant Notice issued under the Ocuphire Pharma, Inc. 2020 Equity Incentive Plan (Filed With SEC on March 30, 2023)
- Form of Option Agreement issuable under the Ocuphire Pharma, Inc. 2018 Equity Incentive Plan (Filed With SEC on July 6, 2020)
- First Amendment to 2018 Equity Incentive Plan, dated as of December 23, 2019 (Filed With SEC on July 6, 2020)
- Ocuphire Pharma, Inc. 2018 Equity Incentive Plan, dated as of April 9, 2019 (Filed With SEC on July 6, 2020)
- Bonus Letter Agreement, dated August 2, 2016, by and between Rexahn Pharmaceuticals, Inc. and Ely Benaim, M.D (Filed With SEC on August 5, 2016)
